← Eichor
Study identifier: NCT01492036 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Long-Term Follow-Up of Recipient of Gene Transfer Research

Condition: Retroviridae Infections · Cancer  ·  Sponsor: M.D. Anderson Cancer Center

PhaseN/A
Planned participants130
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

The goal of this clinical research study is to collect information about the long-term safety of gene transfer therapy. This study is also designed to create a database of medical information about patients who have received gene transfer therapy, in order for researchers to track and review the long-term safety and any effects (good or bad) of gene transfer therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Partow Kebriaei, MD  ·  713-792-8750  ·  pkebriae@mdanderson.org

Always discuss trial participation with your own doctor first.

Locations (1)

University of Texas MD Anderson Cancer CenterHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01492036